Under patronage of Barakat Pharmaceutical Industries and as part of the activities of the nineteenth conference of the Syrian Diabetes Society, a lecture – titled PIOGLIT MET; advantages of combining two insulin sensitizers - has been held.
On the occasion of launching PIOGLIT MET and the official announcement of registering Barakat as the first Syrian Pharmaceuticals in GCC-DR, Barakat has honored:
- Dr Mulhem El-Melhuhi – Director of Hims Health Directorate.
- Dr Najat Seneej – Head of the Syrian Society of Diabetes.
- Dr Nizar Al-Bash – Head of Endocrine Glands Association.
- Conference guests and lecturers.
The lecture was also followed by awarding prizes to physicians who participated in the questionnaire which took place on the sidelines of the conference.